Skip to main content
. 2015 Jul 24;4(10):1505–1513. doi: 10.1002/cam4.497

Figure 2.

Figure 2

Kaplan–Meier estimates of progression-free survival and overall survival in subgroups of patients defined according to early tumor shrinkage (in 43 patients), surgical resection (in 53 patients), or K-ras mutation status (in 40 evaluable patients).